Dexrazoxane ... those drugscauseTorsades de Pointes
Anticancer drugsmay causetorsades de pointes
Fibrosis DrugscausingTorsades de Pointes
many antiarrhythmic drugscan causetorsades de pointes
lots of different drugs that prolong the QT interval(passive) can be caused byTorsades de Pointes
this medicine ... non - antiarrhythmic drugscan causetorsades de pointes
This medication ... non - antiarrhythmic drugscan causetorsades de pointes
several different types of drugscan causetorsade de pointes
501 - 508 Fourteen drugs have been removed from the market worldwidecausetorsade de pointes
significant potentialto causetorsade de pointes
any direct potentialto causetorsades de pointes
drugs or conditions that delay ventricular repolarization(passive) may be caused byTorsade de pointes
that all class III antiarrhythmic drugs inhibit this currentprovokingtorsades de pointes
Translational Regulatory Science Fourteen drugs have been removed from the market worldwidecausetorsade de pointes
drugs that prolong the rate - corrected QT ( QTc ) interval(passive) is ... triggered byTorsade de pointes
Atropine - like side effects Drugscan causeTorsades de pointes
as a side effect of certain drugs ( including most of the antiarrhythmic drugs(passive) is usually causedTorsades de pointes
the development of early afterdepolarizationsto causetorsades de pointes
long axn potential(passive) Can be caused byTorsades de pointes
tendencyto causetorsades de pointes
new arrhythmias ... Early afterdepolarizations (can causetorsades de pointes
Warner B , Hoffmann P. Investigation of the potential of clozapineto causetorsade de pointes
Warner B , Hoffman P. Investigation of the potential of clozapineto causetorsades de pointes
At this time QT prolongation resultscan triggertorsades de pointes
high - dose intravenous haloperidol in cardiac patients(passive) caused by76281364.Torsade de pointes
Prolonged QT interval (to preventtorsades de pointes
belinostat infusion daysmay causeTorsade de Pointes
A Grant , JV Tranquillo , " Action Potential and QT Prolongation not Sufficientto causeTorsade de Pointes
Serious Quinidine / AmiodaronecausesTorsade de pointes
Hydroxychloroquine ... is knownto sometimes provoketorsade de pointes
papaverine ... has been knownto causeTorsades de Pointes
Cardiotoxicity ... knownto causetorsades de pointes
a small dose of risperidone in a terminally ill cancer patient(passive) caused byTorsades de pointes
Early Ventricular Escape Beats in a Patient with Complete Atrioventricular Block Volume 2016(passive) Triggered byTorsade de Pointes
Dofetilide therapy ... excessive QT prolongationcan causetorsades de pointes
S Hunt N - acetyl procainamidecausingtorsades de pointes
two antithyroid drugs most serious side effect of anti - thyroid drugs what drugcan causetorsades de pointes
to syncope or sudden cardiac deathmay leadto syncope or sudden cardiac death
hypotension or degenerate into ventricular fibrillation and sudden cardiac deathcan causehypotension or degenerate into ventricular fibrillation and sudden cardiac death
to syncope , seizures , or sudden deathmay leadto syncope , seizures , or sudden death
to sudden cardiac death ( SCDmay leadto sudden cardiac death ( SCD
syncope or sudden death ( 119 , 120causingsyncope or sudden death ( 119 , 120
to ventricular fibrillation and deathleadingto ventricular fibrillation and death
sudden death ( Thomas , 1994may causesudden death ( Thomas , 1994
aborted sudden death and syncopes(passive) caused byaborted sudden death and syncopes
to ventricular fibrillation , which may cause sudden cardiac deathcan leadto ventricular fibrillation , which may cause sudden cardiac death
to sudden death if proper treatment is not receivedmay leadto sudden death if proper treatment is not received
to syncope and in severe cases , sudden cardiac death.1 , 2leadsto syncope and in severe cases , sudden cardiac death.1 , 2
to lethal ventricular fibrillationleadingto lethal ventricular fibrillation
as with any type of ventricular fibrillationcausesas with any type of ventricular fibrillation
causing deathmay resultcausing death
to arrhythmia and deathcan leadto arrhythmia and death
in syncopal episodes and even sudden cardiac death in young , otherwise healthy individualsresultingin syncopal episodes and even sudden cardiac death in young , otherwise healthy individuals
from the addition of droperidol to an existing cytochrome P450 drug interactionresultingfrom the addition of droperidol to an existing cytochrome P450 drug interaction
syncope ( or pre - syncopecausessyncope ( or pre - syncope
lack of consciousness , known as syncope , or even a cardiac arrest , which can lead to deathcan causelack of consciousness , known as syncope , or even a cardiac arrest , which can lead to death
to tachycardia that leads to deathleadsto tachycardia that leads to death
to brain damage and ultimately deathcan leadto brain damage and ultimately death
to VENTRICULAR FIBRILLATION , in which the ventricular contractions are rapid , irregular , and nonfunctionalcan quickly leadto VENTRICULAR FIBRILLATION , in which the ventricular contractions are rapid , irregular , and nonfunctional
the syncopal attack(passive) caused bythe syncopal attack
fainting , permanent brain damage , and even deathcan causefainting , permanent brain damage , and even death
prolonged QT interval and cardiac arrest(passive) caused byprolonged QT interval and cardiac arrest
lack of consciousness , known as syncope , or even [ medicalnewstoday.comcan causelack of consciousness , known as syncope , or even [ medicalnewstoday.com
to ventricular tachycardia and death whatare the three requirements for re - entrycan leadto ventricular tachycardia and death whatare the three requirements for re - entry
to ventricular fibrillation , a dangerous form of arrhythmia that causes rapid , uncoordinated contractions in the muscle fibers of the ventriclescan also leadto ventricular fibrillation , a dangerous form of arrhythmia that causes rapid , uncoordinated contractions in the muscle fibers of the ventricles
recurrent syncope in a patient taking racemic methadone 120 mgcausingrecurrent syncope in a patient taking racemic methadone 120 mg
to ventricular fibrillation during exercise who harbored the Arg100Gly mutation in the KCNH2 gene as well as the Asp1819Asn mutation in the SCN5A geneleadingto ventricular fibrillation during exercise who harbored the Arg100Gly mutation in the KCNH2 gene as well as the Asp1819Asn mutation in the SCN5A gene
insufficient awareness ... referred to as syncope , or perhaps a cardiac event , be responsible for dyingmay causeinsufficient awareness ... referred to as syncope , or perhaps a cardiac event , be responsible for dying
from the addition of droperidol to an aleve and cymbalta cymbata P450 drug interactionresultingfrom the addition of droperidol to an aleve and cymbalta cymbata P450 drug interaction
not only from disturbances of repolarization but also from disturbances of conductioncan resultnot only from disturbances of repolarization but also from disturbances of conduction
from the addition of droperidol to employee stock options worthless existing cytochrome P450 drug interactionresultingfrom the addition of droperidol to employee stock options worthless existing cytochrome P450 drug interaction
from excessive drug - induced QT - interval prolongationresultingfrom excessive drug - induced QT - interval prolongation